BofA/Merrill Lynch Downgrades Emerson (EMR) to Neutral
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $157.26 +1.64%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Emerson (NYSE: EMR) from Buy to Neutral.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- BofA truck shipper survey shows demand outlook rises modestly
- Deutsche Bank Downgrades Straumann Holding AG (STMN:SW) (SAUHF) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
